CARDIOTESTRONE
Live / Registered — Registered (as of 02 Mar 2021)
What this means for you
Registered since 02 Mar 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 02 Mar 2027, and its filing window is open now).
Record
- Serial number
- 87522958
- Registration number
- 6283414
- Mark type
- Word mark
- Filed
- 11 Jul 2017
- Published for opposition
- 14 Nov 2017
- Registered
- 02 Mar 2021
- Next maintenance filing
- §8 declaration of use, due by 02 Mar 2027 (grace period to 02 Sept 2027)
- Attorney of record
- Scott D. Woldow
Goods and services
- Class 005 — Pharmaceuticals: Dietary supplements; Nutritional supplements
Owner
- Arcopharma S.A., Geneva, CH
- Arcopharma S.A., Geneva, CH
- Arcopharma S.A., Geneva, CH
Prosecution history
- 02 Mar 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Mar 2021 — REGISTERED-PRINCIPAL REGISTER
- 23 Jan 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Jan 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Jan 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Jan 2021 — USE AMENDMENT FILED
- 11 Jan 2021 — TEAS STATEMENT OF USE RECEIVED
- 22 Jul 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jul 2020 — SOU EXTENSION 5 GRANTED
- 01 Jul 2020 — SOU EXTENSION 5 FILED
- 21 Jul 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Jul 2020 — SOU TEAS EXTENSION RECEIVED
- 08 Jan 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jan 2020 — SOU EXTENSION 4 GRANTED
- 06 Jan 2020 — SOU EXTENSION 4 FILED